LVTX and XOMA Related Headlines
Go Back- XOMA completes acquisition of LAVA Therapeutics for $1.04 per share
- XOMA Royalty Announces Closing of Transactions to Acquire LAVA Therapeutics N.V.
- LAVA Therapeutics N.V. Shareholders are Reminded to Tender Shares for XOMA Royalty Transaction Before November 12, 2025 Deadline
LVTX and XOMA Related Press Releases
Go Back- XOMA Royalty Announces Closing of Transactions to Acquire LAVA Therapeutics N.V.
- LAVA Therapeutics N.V. Shareholders are Reminded to Tender Shares for XOMA Royalty Transaction Before November 12, 2025 Deadline


